A new type of covid vaccine which can be snorted or taken as a pill has passed animal trials in Basel.
The University of Basel says the vaccine is based on a modified coronavirus that will trigger an immune response, but won’t multiply in the body.
It’s been developed with the company RocketVax.
It can also be quickly adapted to account for new variants and it’s easier to store.
Human trials are the next stage.
Hottest summer ever
Vaud celebrates international music star
Zurich HB wins another award
Another controversial vote at end of September
US tourism from Switzerland slumps
Home hunting even more challenging
